Influenza A virus A/Brisbane/02/2018 IVR-190 (H1N1) antigen (formaldehyde inactivated)

DB15515ApprovedVaccines

Influenza A virus A/Brisbane/02/2018 IVR-190 (H1N1) antigen (formaldehyde inactivated) is an inactivated influenza antigen used in seasonal influenza vaccines. A seasonally-specific component of the influenza vaccine.

First approval: United States, 2015
Brand names: Fluzone High-dose

Resolves to

Compound

UNIIXW4JB03TI5

What you can answer from here — as of June 04, 2026

14Clinical trialsPhase, status and sponsor resolved per trial

1ContraindicationEach with its own population and attribute set

18Marketed productsAcross 5 countries and 8 labellers

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Influenza A virus A/Brisbane/02/2018 IVR-190 (H1N1) antigen (formaldehyde inactivated), in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account